Table 6.3

Placebo controlled trials of budesonide for maintenance of medically induced remission in Crohn’s disease

AuthorYearNumber of patientsDose (mg/day)Duration (months)Relapse rate (%)DrugRef section 2
BudesonidePlacebop Value
Löfberg1996906127463NSEntocort122
359
Greenberg19961056126167NSEntocort123
370
Ferguson1998756124660NSEntocort124
348
Gross19981793126765NSBudenofalk125